|
Prism Medico and Pharmacy Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
8.32 Cr.
|
P/BV
|
0.55
|
Book Value (Rs.)
|
24.97
|
|
52 Week High/Low (Rs.)
|
37/12
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 |
| | | | |
| PER SHARE RATIOS | | | |
| | | | |
| Basic EPS (Rs.) | 0.07 | -0.01 | -0.36 |
| Diluted EPS (Rs.) | 0.07 | -0.01 | -0.36 |
| Cash EPS (Rs.) | 0.69 | 0.72 | -0.02 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 21.29 | 21.23 | 21.23 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 21.29 | 21.23 | 21.23 |
| Revenue From Operations / Share (Rs.) | 89.76 | 37.61 | 8.70 |
| PBDIT / Share (Rs.) | 0.64 | 1.32 | 0.21 |
| PBIT / Share (Rs.) | 0.01 | 0.58 | -0.12 |
| PBT / Share (Rs.) | -0.15 | 0.11 | -0.35 |
| Net Profit / Share (Rs.) | 0.06 | -0.01 | -0.36 |
| NP After MI And SOA / Share (Rs.) | 0.06 | -0.01 | -0.36 |
| | | | |
| PROFITABILITY RATIOS | | | |
| | | | |
| PBDIT Margin (%) | 0.72 | 3.52 | 2.49 |
| PBIT Margin (%) | 0.01 | 1.56 | -1.41 |
| PBT Margin (%) | -0.17 | 0.29 | -4.02 |
| Net Profit Margin (%) | 0.07 | -0.01 | -4.14 |
| NP After MI And SOA Margin (%) | 0.07 | -0.01 | -4.14 |
| Return on Networth / Equity (%) | 0.31 | -0.03 | -1.69 |
| Return on Capital Employeed (%) | 0.08 | 2.74 | -0.47 |
| Return On Assets (%) | 0.18 | -0.02 | -1.26 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.23 |
| Total Debt / Equity (X) | 0.17 | 0.16 | 0.25 |
| Asset Turnover Ratio (%) | 2.94 | 1.38 | 0.00 |
| | | | |
| LIQUIDITY RATIOS | | | |
| | | | |
| Current Ratio (X) | 1.31 | 1.35 | 5.22 |
| Quick Ratio (X) | 1.14 | 0.82 | 2.79 |
| | | | |
| COVERAGE RATIOS | | | |
| | | | |
| Interest Coverage Ratio (%) | 3.67 | 2.78 | 0.95 |
| Interest Coverage Ratio (Post Tax) (%) | 1.37 | 0.98 | -0.58 |
| | | | |
| VALUATION RATIOS | | | |
| | | | |
| Enterprise Value (Cr.) | 24.30 | 15.28 | 24.77 |
| EV / Net Operating Revenue (X) | 0.44 | 0.67 | 4.70 |
| EV / EBITDA (X) | 61.76 | 19.02 | 188.23 |
| MarketCap / Net Operating Revenue (X) | 0.41 | 0.63 | 4.45 |
| Price / BV (X) | 1.74 | 1.12 | 1.82 |
| Price / Net Operating Revenue (X) | 0.41 | 0.63 | 4.45 |
| EarningsYield | 0.00 | 0.00 | -0.01 |
